Research Topics
Species | D ChabasSummaryAffiliation: University of California Country: USA Publications
|
Detail Information
Publications
Pediatric multiple sclerosisDorothee Chabas
University of California at San Francisco, Multiple Sclerosis Center, 94117, USA
NeuroRx 3:264-75. 2006..As a result, children are receiving adult therapies in an arbitrary manner and our understanding of pediatric treatment effect and tolerability is limited. Available data on tolerability of approved drugs for adults is reviewed...
Pediatric multiple sclerosisDorothee Chabas
University of California, San Francisco, Regional Pediatric Multiple Sclerosis Center, 350 Parnassus Avenue, Suite 908, San Francisco, CA 94117, USA
Curr Neurol Neurosci Rep 8:434-41. 2008..The rareness of pediatric-onset MS has precluded enrollment in clinical trials. Thus, children are receiving off-label adult therapies without clear evidence of their effectiveness and limited knowledge of their tolerability...
Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?D Chabas
UCSF Regional Pediatric Multiple Sclerosis Center, San Francisco, CA 94117, USA
Neurology 71:1090-3. 2008..Pediatric patients with MS may less often meet MRI diagnostic criteria for adults. Whether initial MRI presentation is distinct in prepubertal patients is unknown...
Common viruses associated with lower pediatric multiple sclerosis riskE Waubant
UCSF Regional Pediatric Multiple Sclerosis Center, 350 Parnassus Ave, Suite 908, San Francisco, CA 94117, USA
Neurology 76:1989-95. 2011..We studied seroprevalence for Epstein-Barr virus (EBV), cytomegalovirus (CMV), and herpes simplex virus (HSV) type 1 and HLA-DRB1*1501/1503 status as predictors of pediatric MS...
Younger children with MS have a distinct CSF inflammatory profile at disease onsetD Chabas
UCSF Regional Pediatric MS Center, 350 Parnassus Ave, Suite 908, San Francisco, CA 94117, USA
Neurology 74:399-405. 2010..The clinical and MRI presentation differs between earlier- and later-onset pediatric multiple sclerosis (MS), whereas the effect of age on the CSF inflammatory profile is unknown and may contribute to delayed diagnosis...
